Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
7.76
+0.73 (10.39%)
At close: Sep 18, 2024, 4:00 PM
7.72
-0.04 (-0.45%)
After-hours: Sep 18, 2024, 7:57 PM EDT

Candel Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
--0.130.130.130.13
Cost of Revenue
21.6623.9820.3514.59-6.61
Gross Profit
-21.66-23.98-20.22-14.470.13-6.48
Selling, General & Admin
13.9914.4114.511.265.992.56
Research & Development
----7.94-
Operating Expenses
13.9914.4114.511.2613.942.56
Operating Income
-35.65-38.39-34.72-25.73-13.81-9.04
Interest Expense
-2.56-2.6-1.71-0.05--
Interest & Investment Income
1.482.081.22-0.111.07
Other Non Operating Income (Expenses)
-13.260.9716.42-10.81-3.98-0.27
EBT Excluding Unusual Items
-49.99-37.94-18.79-36.59-17.68-8.24
Other Unusual Items
---0.46--
Pretax Income
-49.99-37.94-18.79-36.12-17.68-8.24
Net Income
-49.99-37.94-18.79-36.12-17.68-8.24
Net Income to Common
-49.99-37.94-18.79-36.12-17.68-8.24
Shares Outstanding (Basic)
292929191212
Shares Outstanding (Diluted)
292929191212
Shares Change (YoY)
1.16%0.39%52.72%62.49%0.71%-
EPS (Basic)
-1.71-1.31-0.65-1.91-1.52-0.71
EPS (Diluted)
-1.71-1.31-0.65-1.91-1.52-0.71
Free Cash Flow
-31.03-34.7-32.72-24.05-10.55-5.34
Free Cash Flow Per Share
-1.06-1.20-1.14-1.27-0.91-0.46
Gross Margin
----100.00%-
Operating Margin
---27777.60%-20580.80%-11048.00%-7229.60%
Profit Margin
---15035.20%-28899.20%-14144.00%-6592.00%
Free Cash Flow Margin
---26172.80%-19242.40%-8437.60%-4268.80%
EBITDA
-34.66-37.43-33.94-25.49-13.72-8.99
D&A For EBITDA
0.990.960.780.230.090.04
EBIT
-35.65-38.39-34.72-25.73-13.81-9.04
Source: S&P Capital IQ. Standard template. Financial Sources.